CRISPR (CRSP), Intellia (NTLA), Caribou, ERS Genomics Provide Update on CRISPR/Cas9 US Patent Interference … – StreetInsider.com
|
CRISPR (CRSP), Intellia (NTLA), Caribou, ERS Genomics Provide Update on CRISPR/Cas9 US Patent Interference …
StreetInsider.com The USPTO has rejected a series of patent applications filed by Broad that are directed to uses of CRISPR/Cas9 Technology in eukaryotic cells (as in the claims involved in the interference) as being “non-novel” in view of the UC's prior-filed patent … The Intellia Therapeutics Inc (NTLA) Stock Rating Decreased by the Zacks Investment Research |
